1 Product identity
Ingredient risk
Contains restricted ingredients
DHEA-10 mg
BrandBiotics Research Corporation→Fat/Fatty Acid Tablet or Pill 4 ingredients 1 banned 1 caution DSLD #21676Net contents: 180 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-05-24
2 Ingredients (4)
IngredientGroupSafety
CelluloseCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
DHEA 🇨🇦 🇬🇧 🇪🇺 🇦🇺 — Not approved for OTC sale as supplement.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
DHEA — Banned in ≥1 country
⚠ Hormonal: acne, hirsutism, voice deepening
⚠ May promote hormone-sensitive cancers
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
5 Data source
DSLD ID21676
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-05-24
6 More from Biotics Research Corporation
View Biotics Research Corporation Safety Scorecard → 240 products
5-HTP7-Keto-ZymeA.D.P.Acetyl-L-CarnitineADB5-PlusADHS7 Cite this page
Vancouver
Pkhakadze G. DHEA-10 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 31]. Available from: https://supplement.ge/products/dhea-10-mg-21676/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG